NSAV Holding Inc (NSAV)

[MIKEY501]

*** NSAV 1-17-2018 MEGA NEWS ***

NSAV Announces Elimination of Toxic Debt and No Reverse Split of Its Shares

GLOBENEWSWIRE 7:13 AM ET 1/17/2018


CRESCO, PA, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Net Savings Link, Inc.(NSAV) , announced today that all $240,000.00 of toxic convertible debt has been eliminated from its books and can no longer negatively impact the Company or its shareholders. The current management of NSAV inherited these five toxic convertible notes from the prior management, all of which dated back to 2014. Since taking over in 2016, the Company’s current management has not authorized the issuance of a single share of its common stock, except for a restricted stock dividend enacted in May 2017. The Company wants to assure all NSAV shareholders that it is firmly standing by its previously stated commitment of no dilution.


The Company also announced today in response to numerous shareholder inquiries, that NSAV is categorically not planning or even considering a reverse split of its shares. Since the current management took over in February 2016, the Company imposed a strategy of building the company from the ground up and reverse stock splits are almost always detrimental to shareholders.

NSAV also announced that the collaboration between its subsidiary, Shanghai based Vital Strategic Research Institute (VSRI) and Eli Lilly and Company ( www.lilly.com ) is proceeding according to schedule. VSRI and Eli Lilly signed an agreement on December 5, 2017. Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease (CVD) among newly diagnosed diabetes patients at increased risk of CVD in China. China is facing the largest diabetes epidemic in the world with around 11 percent of its population suffering from the metabolic illness, while nearly 36 percent are pre-diabetic. CVD in China has also reached epidemic proportions, with over 200 million Chinese suffering from the world’s leading cause of death. A copy of the NSAV/VSRI-Eli Lilly agreement can be viewed on the NSAV corporate website by accessing the link below.

http://nsavholdinginc.com/files/VSRI-Eli-Lilly.pdf

James Tilton, president of NSAV stated, “I am thrilled that we have been able to eliminate this huge amount of toxic convertible debt from our books, which has been hanging over the Company’s head for over three years. Now we can look forward to a great 2018.”

Mr. Tilton went on to state, “I am not sure where these continued rumors of a reverse split keep coming from. As I have stated on numerous occasions, NSAV will never do a reverse split as long as I am its president.”

Mr. Tilton went on to further state, “I am so pleased that the Eli Lilly deal is progressing nicely. I can assure all NSAV shareholders that we are working on more major deals like this one.”

NSAV's vision is the establishment of a fully integrated technology and software company that provides turnkey technological and software solutions to the medical industry. Over time, the Company plans to provide a wide range of services such as software solutions, e-commerce, advisory services, financial services, patents and trademarks and information technology.

For further information please contact NSAV at 1 [phone] or [e-mail]

The NSAV corporate email address is [e-mail]

The NSAV corporate website can be accessed at http://nsavholdinginc.com

The NSAV Twitter account can be accessed at https://twitter.com/NSAV_MJTechCo

The NSAV Facebook account can be accessed at https://www.facebook.com/NSAVHolding